Dr. Argeris (jerry) N. Karabelas
Board of Directors
Partner, Capital Care LLC
VALEANT Pharmaceuticals International. Inc.
Canada
Biography
Dr. Karabelas has been serving on the Board since June 2016. Since December 2001, Dr. Karabelas has been a Partner at Care Capital, LLC, a life sciences venture firm. Prior to Care Capital, he was the founder and Chairman at Novartis BioVenture Fund. He served as Head of Healthcare and CEO of worldwide pharmaceuticals for Novartis Pharma AG from 1998 to 2000, with responsibilities for Novartis Pharma, Ciba Vision, Generics and strategic and operational leadership of R&D. Before joining Novartis, Dr. Karabelas was Executive Vice President of SmithKline Beecham responsible for U.S. and European operations, regulatory and strategic marketing. He has served on several boards of pharmaceutical and therapeutics companies, including Renovo, plc; Vanda Pharmaceuticals, Inc.; NitroMed, Inc.; SkyePharma, plc; Human Genome Sciences; and Inotek Pharmaceuticals. Dr. Karabelas has been serving on the Board since June 2016. Since December 2001, Dr. Karabelas has been a Partner at Care Capital, LLC, a life sciences venture firm. Prior to Care Capital, he was the founder and Chairman at Novartis BioVenture Fund. He served as Head of Healthcare and CEO of worldwide pharmaceuticals for Novartis Pharma AG from 1998 to 2000, with responsibilities for Novartis Pharma, Ciba Vision, Generics and strategic and operational leadership of R&D. Before joining Novartis, Dr. Karabelas was Executive Vice President of SmithKline Beecham responsible for U.S. and European operations, regulatory and strategic marketing. He has served on several boards of pharmaceutical and therapeutics companies, including Renovo, plc; Vanda Pharmaceuticals, Inc.; NitroMed, Inc.; SkyePharma, plc; Human Genome Sciences; and Inotek Pharmaceuticals.
Research Interest
Business and Pharmaceuticals
